IPEC e-newsletter - Excipients Insight April 2017 - 30-04-17

 

Inside this issue

     

Report on first 2017 IPEC Europe Board meeting

At the beginning of the month, The IPEC Europe Board held its first face-to-face meeting of 2017.  After the presentation made at the Annual General Meeting in Monte Carlo, it's the time when the real work starts and plans are refined and actions taken. You may recall that the Board has established its Agenda 2020 and the accompanying Roadmap defining the activities required to take IPEC Europe there. The Roadmap identifies eight pathways, and the ownership of each is assigned to Board members.

A significant amount of time was dedicated to reporting progress and potential barriers which need to be removed in order to achieve the goals targeted for this year. It is good to note particularly that in the areas of communication and knowledge sharing, great steps have already been taken. The website redesign is underway with a 'go live' date aimed at Q3 and very soon webinar events will be launched to align with the publication of the recently revised GMP and GDP Guides.

IPEC Europe, in a bid to enhance awareness of our endeavours is scheduled to exhibit and/or present at several events including AFI 57e Simposio (Rimini, June), ExcipientFest Asia (Beijing, July), PowTech (Nuremberg, September),and the APV/IPEC Europe Conference (Berlin, September). Of course it is hoped that these activities will help to support member recruitment which is a key strategic initiative for 2017.

Another key focus area where things are starting to happen is stakeholder collaboration. Following the signing of a Memorandum of Understanding with EFCG in 2016, work has begun to raise awareness at the higher levels in the EU of the importance and contribution of APIs and pharmaceutical excipients in the supply of medicines. While a series of tools to enable us to communicate this message will be created, IPEC Europe's first step is to develop an infographic related to excipients, their development, supply and use, in parallel with EFCG for APIs.   

As the Pharmacopoeial Review & Harmonisation Committee is currently in a state of flux while new leaders are sought, consideration was given as to how this important group could be reconfigured to improve its effectiveness in supporting the harmonisation agenda. With the support of the Board, the PR&HC did meet on 25 April, a report of which will be included in the May edition of Excipients Insight.   

Finally, the Election of Officers following the AGM took place as is required by our Articles of Association.

IPEC Federation update

IPEC Europe Board agendas routinely include an update on the work plan of the IPEC Federation which on this occasion was delivered by its President, Dr Patricia Rafidison.  Patricia reported that the Federation is keen to make its undertakings ever more transparent to the broader IPEC community in 2017 by attending events held by the IPEC sister associations. Key to this is the release of position papers on very important global issues such as data integrity and atypical actives, as they relate to excipients. It is hoped a future edition of Excipients Insight, will include an interview with Patricia where these and other Federation issues can be explored.

 

 

 

Copyright © 2005 - 2017 IPEC Europe - International Pharmaceutical Excipients Council